__timestamp | Eli Lilly and Company | Regeneron Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 14683100000 | 2614539000 |
Thursday, January 1, 2015 | 14921500000 | 3711019000 |
Friday, January 1, 2016 | 15567200000 | 4560733000 |
Sunday, January 1, 2017 | 16801100000 | 5475166000 |
Monday, January 1, 2018 | 16811600000 | 6276700000 |
Tuesday, January 1, 2019 | 17598300000 | 7081200000 |
Wednesday, January 1, 2020 | 19056500000 | 7377200000 |
Friday, January 1, 2021 | 21005600000 | 13634200000 |
Saturday, January 1, 2022 | 21911600000 | 10612500000 |
Sunday, January 1, 2023 | 27041900000 | 11301400000 |
Monday, January 1, 2024 | 12231500000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical industry, Eli Lilly and Regeneron Pharmaceuticals have showcased remarkable growth in gross profit over the past decade. From 2014 to 2023, Eli Lilly's gross profit surged by approximately 84%, reaching its peak in 2023. This growth reflects the company's strategic innovations and market expansions.
Meanwhile, Regeneron Pharmaceuticals demonstrated an impressive growth trajectory, with its gross profit increasing by over 330% during the same period. The year 2021 marked a significant milestone for Regeneron, as it achieved its highest gross profit, driven by its groundbreaking advancements in biotechnology.
This comparative analysis highlights the dynamic shifts in the pharmaceutical sector, where both companies have capitalized on their unique strengths. As the industry continues to evolve, these giants remain at the forefront, setting benchmarks for profitability and innovation.
Eli Lilly and Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Eli Lilly and Company vs Johnson & Johnson: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Eli Lilly and Company vs Genmab A/S
Who Generates Higher Gross Profit? Eli Lilly and Company or Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Eli Lilly and Company or Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Eli Lilly and Company vs Amphastar Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Walgreens Boots Alliance, Inc.
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown